Case Study

APT Pharma Limited has acquired Universal Pharmaceutical Labs

APT Pharma Limited, a subsidiary of Jacobson Pharma Group, has acquired the entire shareholding in Universal Pharmaceutical Laboratories Ltd, a subsidiary of Li & Fung Group, for US$10.8 million.

APT Pharma Limited is a leading pharmaceutical manufacturer in Hong Kong, with manufacturing plants in both Hong Kong and Zhongshan.

Universal Pharmaceutical Laboratories Ltd manufactures and distributes private labeled pharmaceuticals, imported pharmaceuticals, health food and nutritional supplements, and various health and beauty care products in Hong Kong.

Li & Fung Group operates three core businesses: it designs, develops and sources consumer products for retailers worldwide; the group operates extensive logistics and distribution networks serving major brands globally. Another core business is retailing, where the company offers convenience stores and bakeries through Convenience Retail Asia Limited, luxury menswear through Trinity Limited, and toys and children's products through Toys (Labuan) Holding Limited.

Oaklins' team in Hong Kong advised the shareholders of APT Pharma Limited in this transaction.

Tombstone image for APT Pharma Limited has acquired Universal Pharmaceutical Labs

KEY DEAL CONTACTS

Richard Winter

China

Managing Partner

VIEW PROFILE